A61K 45 - Medicinal preparations containing active ingredients not provided for in groups

Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020)
11/2002
11/28/2002	WO2002094203A2 Inhibitors of macrophage migration inhibitory factor and methods for identifying the same
11/28/2002	WO2002094202A2 Methods for protecting allogeneic islet transplant using soluble ctla4 mutant molecules
11/28/2002	WO2002094196A2 Method of treatment for cancers associated with elevated
11/28/2002	WO2002094194A2 Compositions and methods for inhibiting metastasis
11/28/2002	WO2002094189A2 Compositions and methods for treating or preventing convulsions or seizures
11/28/2002	WO2002094187A2 Novel use
11/28/2002	WO2002094186A2 Urazole compounds useful as anti-inflammatory agents
11/28/2002	WO2002094180A2 Pharmaceutically active isoindoline derivatives
11/28/2002	WO2002094176A2 Use of compounds with combined nep/mp-inhibitory activity on the preparation of medicaments
11/28/2002	WO2002094021A1 A combination and method of treatment of cancer utilizing a cox-2 inhibitor and an hmg-coa inhibitor and cystine to enhance glutathione
11/28/2002	WO2002094018A1 Compositions comprising d-chiro inositol and lipid lowering compounds and methods of treatment thereof
11/28/2002	WO2002093998A2 Suppression of allergic reactions by transdermal administration of allergens in conjunction with or conjugated to toxin subunits or fragments thereof
11/28/2002	WO2002083712A8 Transporters and ion channels
11/28/2002	WO2002083176A8 Biomaterials comprising a melanocyte stimulating hormone (msh), and method of forming
11/28/2002	WO2002080887A3 Timed pulse release composition
11/28/2002	WO2002080859A3 Inhalation drug combinations
11/28/2002	WO2002080858A3 Use of kpv tripeptide for dermatological disorders
11/28/2002	WO2002079408A3 Short bioactive peptides and methods for their use
11/28/2002	WO2002078745A3 Use of mglur5 antagonists in the manufacture of a medicament in the treatment of autism, mental retardation, schizophrenia
11/28/2002	WO2002078629A3 Acute pharmacologic augmentation of psychotherapy with enhancers of learning or conditioning
11/28/2002	WO2002072631A8 Mhc molecule constructs and their usesfor diagnosis and therapy
11/28/2002	WO2002072080A3 Paracetamol solutions which are stable in storage and ready for infusion
11/28/2002	WO2002072008A9 Method for treating cancer using a33 specific antibodies and chemotherapeutic agents
11/28/2002	WO2002070563A3 Nuclear hormone receptor ligand binding domain
11/28/2002	WO2002062322A3 Glycine betaine and its use as anti-hemorrhagic agent
11/28/2002	WO2002058683A3 Carotenoids as anti-hypertension agents
11/28/2002	WO2002036733A3 Cd36 as a heat shock protein receptor and uses thereof
11/28/2002	WO2002035235A3 Net as regulator of angiogenic expression
11/28/2002	WO2002024924A3 Protein phosphatases
11/28/2002	WO2002020002A3 A method for treating allergies
11/28/2002	WO2002015977A3 Methods and compositions for treating ige-related disease using nnt-1 inhibitors
11/28/2002	WO2002009759A3 Aldosterone antagonist and cyclooxygenase-2 inhibitor combination therapy to prevent or treat inflammation-related cardiovascular disorders
11/28/2002	WO2002008255A3 Cell cycle proteins and mitosis-associated molecules
11/28/2002	WO2001096329A1 Medicinal compositions containing propenone derivatives
11/28/2002	WO2001095919A3 A recombinant non-replicating virus expressing gm-csf and uses thereof to enhance immune responses
11/28/2002	WO2001082897A3 Liposome drug delivery
11/28/2002	WO2001081415A3 Parathyroid hormone and parathyroid hormone-related protein antagonists
11/28/2002	WO2001035942A9 Analgesic compositions containing buprenorphine
11/28/2002	US20020178459 Genetically engineered mammal for use in the treatment of muscle and liver disorders
11/28/2002	US20020177689 Compounds for the treatment of sexual dysfunction
11/28/2002	US20020177624 Prevents vaginitis
11/28/2002	US20020177618 ERK (extracellular signal regulated kinase) inhibitors for treatment of cancer, inflammatory disorders, restenosis, and cardiovascular disease
11/28/2002	US20020177617 Method of treating migraines and pharmaceutical compositions
11/28/2002	US20020177614 Preventing neural tissue damage caused by adenosine-diphosphate- ribosylation of eucaryotic elongation factor-2 (EF-2)
11/28/2002	US20020177603 5,10-dihydrobenzo(b)(1,8)naphthyridine compounds, N-oxides; 3,7-Dichloro-5-isopropoxymethyl-5-trifluoromethyl-5,10 -dihydrobenzo(b)(1,8)naphthyridine for example; combination therapy
11/28/2002	US20020177602 Antidiabetic formulation and method
11/28/2002	US20020177593 Non-carbamate amine acetylcholinesterase inhibitor and a carrier; for example, 9-amino-1,2,3,4-tetrahydroacridine or 8-(3-(1-((3-fluorophenyl)methyl)-4-piperidinyl)-1-oxopropyl)-1,2,5,6 -tetrahydro-4H-pyrrolo(3,2,1-ij)quinolin-4-one
11/28/2002	US20020177592 Combination of adrenergic agonist and tricyclo-alkylamine for relieving chronic pain without adverse side effects
11/28/2002	US20020177581 Novel anti-inflammatory androstane derivative
11/28/2002	US20020177559 Inhibitors of cellular efflux pumps of microbes
11/28/2002	US20020177556 Especially treating Alzheimer's disease with cetrorelix.
11/28/2002	US20020177548 Combination therapy using pentafluorobenzenesulfonamides and antineoplastic agents
11/28/2002	US20020177187 Nucleotide sequences coding polypeptide for use in the treatment of nervous system disorders
11/28/2002	US20020177145 Detection and classification of nervous system progenitor cells; obtain tissue, monitor expression of daedalos protein in sample, compare to control, ampified daedalos expression indicates presence of nervous system progenitor cells
11/28/2002	US20020176902 Synergistic proteoglycan compositions for treatment of inflammatory diseases
11/28/2002	US20020176898 Tea catechins in sustained release formulations as cancer specific proliferation inhibitors
11/28/2002	US20020176897 Treating cancer cells that express a membrane protein tNOX, a hormone-insensitive and drug-responsive form of NOX (NADH oxidase) specific to cancer cells
11/28/2002	US20020176891 Topical gel delivery system
11/28/2002	US20020176883 Effects of dietary cation-anion difference (DCAD) and essential fatty acid nutrients on calcium homeostasis in prepartum dairy cattle (hypocalcemia)
11/28/2002	US20020176881 Rehydration composition
11/28/2002	US20020176876 A unique combination of antiinfammatory agent, bactericide, antioxidant, and an exfoliant as first phase, a circulatory enhancement agent, an antiinflammatory agent, a moisturizer as second phase for topical therapeutical skin treatment
11/28/2002	US20020176872 Pain treatment by peripheral administration of a neurotoxin
11/28/2002	US20020176850 Immunotherapy of cancer with allogeneic lymphocytes
11/28/2002	US20020176849 Endomural therapy
11/28/2002	US20020176818 Radionuclide complexed with a chelating agent such as macrocyclic aminophosphonic acid
11/28/2002	DE10123958A1 Identifying ligands for G protein-coupled receptors, useful for treating cardiovascular disease, by using calcium-sensitive fluorophores in cells expressing G alpha proteins
11/28/2002	CA2454551A1 Controlled release drug delivery device
11/28/2002	CA2450685A1 Compositions for the treatment of pigmentation disorders and methods for their manufacture
11/28/2002	CA2450677A1 A novel intein and uses thereof
11/28/2002	CA2449442A1 Combination medicament for treatment of neoplastic diseases
11/28/2002	CA2448253A1 Human cdnas and proteins and uses thereof
11/28/2002	CA2448174A1 Compounds capable of modulating the activity and stimulating the production of a catalytic antibody
11/28/2002	CA2448092A1 Internalisation of virus into cells
11/28/2002	CA2448018A1 Compositions and methods for inhibiting metastasis
11/28/2002	CA2447940A1 Urazole compounds useful as anti-inflammatory agents
11/28/2002	CA2447883A1 Use of nf-kappa-b inhibitors to treat dry eye disorders
11/28/2002	CA2447795A1 Suppression of allergic reactions by transdermal administration of allergens in conjunction with or conjugated to toxin subunits or fragments thereof
11/28/2002	CA2447598A1 Use of compounds with combined nep/mp-inhibitory activity in the preparation of medicaments
11/28/2002	CA2447340A1 Kinases and phosphatases
11/28/2002	CA2447338A1 Receptors and membrane-associated proteins
11/28/2002	CA2447103A1 Inhibitors of macrophage migration inhibitory factor and methods for identifying the same
11/28/2002	CA2447066A1 Method of treatment for cancers associated with elevated
11/28/2002	CA2447063A1 Novel use
11/28/2002	CA2447023A1 Conjugates activated by cell surface proteases and therapeutic uses thereof
11/28/2002	CA2445972A1 Methods and compositions for treating respiratory mucin production associated disease conditions
11/28/2002	CA2445789A1 Combination of an adenosine a2a-receptor agonist and tiotropium or a derivative thereof for treating obstructive airways
11/28/2002	CA2444487A1 Methods and formulations of using a1 adenosine and p2x purinoreceptor antagonists
11/28/2002	CA2441801A1 Methods and formulations for increasing the affinity of a1 adenosine receptor ligands for the a1 adenosine receptor
11/28/2002	CA2427619A1 Pharmaceutically active isoindoline derivatives
11/28/2002	CA2427381A1 Transdermal drug delivery devices having coated microprotrusions
11/28/2002	CA2410763A1 Medicinal compositions containing propenone derivatives
11/27/2002	EP1260591A1 High-efficiency assay for protein mannosyl transferases
11/27/2002	EP1260587A2 Tyrosyl tRNA synthetase
11/27/2002	EP1260233A1 P-glycoprotein modifier-containing medicinal compositions to be delivered to the large intestine
11/27/2002	EP1260228A2 Human growth gene and short stature gene region. Therapeutic uses
11/27/2002	EP1260225A1 A pharmaceutical composition for use in hormone replacement therapy
11/27/2002	EP1259813A2 Diagnosis and treatment of malignant neoplasms
11/27/2002	EP1259812A2 Breast, gastric and prostate cancer associated antigens and uses therefor
11/27/2002	EP1259648A2 Diagnostics and therapeutics for glaucoma
11/27/2002	EP1259647A2 Methods for diagnosing, monitoring, staging, imaging and treating lung cancer via lung cancer specific genes

1 ... 763 764 765 766 767 768 769 770 771 772 773 774 775 776 777 778 779 780 781 782 783 ... 1151